Simultaneous changes of spatial memory and spine density after intrahippocampal administration of fibrillar a β 1-42 to the rat brain

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Borbély, Emke ^a   Horváth, János ^a   Furdan, Szabina ^a   Bozsó, Zsolt ^a   Penke, Botond ^a   Fülöp, Lívia ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; FIBRILLAR AMYLOID BETA PROTEIN[1-42]; UNCLASSIFIED DRUG; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DENDRITIC SPINE; GOLGI STAIN; HIPPOCAMPAL CA1 REGION; LONG TERM MEMORY; MALE; MORRIS WATER MAZE TEST; NERVE DEGENERATION; NONHUMAN; PYRAMIDAL NERVE CELL; RAT; SPATIAL LEARNING; SPATIAL MEMORY; ANIMAL; DRUG EFFECTS; GOLGI COMPLEX; HIPPOCAMPUS; MAZE TEST; METABOLISM; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE; WISTAR RAT;

AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; CA1 REGION, HIPPOCAMPAL; DENDRITIC SPINES; GOLGI APPARATUS; HIPPOCAMPUS; MALE; MAZE LEARNING; PEPTIDE FRAGMENTS; PYRAMIDAL CELLS; RATS, WISTAR; SPATIAL MEMORY;

EID: 84904096737     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/345305     Document Type: Article

References (59)

1. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., Katzman R., Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology 1991 30 4 572 580 2-s2.0-0025987048 10.1002/ana.410300410
2. Allan Butterfield D., Castegna A., Lauderback C. M., Drake J., Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiology of Aging 2002 23 5 655 664 2-s2.0-0036753272 10.1016/S0197-4580(01)00340-2 (Pubitemid 35217687)
3. Kar S., Slowikowski S. P. M., Westaway D., Mount H. T. J., Interactions between β -amyloid and central cholinergic neurons: implications for Alzheimer's disease. Journal of Psychiatry and Neuroscience 2004 29 6 427 441 2-s2.0-11344265672 (Pubitemid 40075714)
4. 1-42 Brain Research 2011 1384 89 96 2-s2.0-79953025369 10.1016/j.brainres.2011.01.103
5. Pause B. M., Zlomuzica A., Kinugawa K., Mariani J., Pietrowsky R., Dere E., Perspectives on episodic-like and episodic memory. Frontiers in Behavioral Neuroscience 2013 2-s2.0-84875972540 10.3389/fnbeh.2013.00033
6. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991 82 4 239 259 2-s2.0-0025863618
7. Butterfield D. A., Perluigi M., Sultana R., Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. European Journal of Pharmacology 2006 545 1 39 50 2-s2.0-33747036919 10.1016/j.ejphar.2006.06.026 (Pubitemid 44215876)
8. Baloyannis S. J., Dendritic pathology in Alzheimer's disease. Journal of the Neurological Sciences 2009 283 1-2 153 157 2-s2.0-67650142070 10.1016/j.jns.2009.02.370
9. Selkoe D. J., Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999 399 6738, supplement A23 A31 2-s2.0-0033600274
10. Selkoe D. J., Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β -protein. Journal of Alzheimer's Disease 2001 3 1 75 81 2-s2.0-0035081475 (Pubitemid 32238253)
11. Mattson M. P., Pathways towards and away from Alzheimer's disease. Nature 2004 430 7000 631 639 2-s2.0-3943092621 10.1038/nature02621 (Pubitemid 39061671)
12. Chabrier M. A., Cheng D., Castello N. A., Green K. N., Laferla F. M., Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease. Neurobiology of Disease 2014 64 107 117
13. Tsai J., Grutzendler J., Duff K., Gan W.-B., Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nature Neuroscience 2004 7 11 1181 1183 2-s2.0-7044220336 10.1038/nn1335 (Pubitemid 39426234)
14. Knafo S., Alonso-Nanclares L., Gonzalez-Soriano J., Merino-Serrais P., Fernaud-Espinosa I., Ferrer I., DeFelipe J., Widespread changes in dendritic spines in a model of Alzheimer's Disease. Cerebral Cortex 2009 19 3 586 592 2-s2.0-59749104724 10.1093/cercor/bhn111
15. Koffie R. M., Meyer-Luehmann M., Hashimoto T., Adams K. W., Mielke M. L., Garcia-Alloza M., Micheva K. D., Smith S. J., Kim M. L., Lee V. M., Hyman B. T., Spires-Jones T. L., Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proceedings of the National Academy of Sciences of the United States of America 2009 106 10 4012 4017 2-s2.0-62649174753 10.1073/pnas.0811698106
16. LaFerla F. M., Green K. N., Oddo S., Intracellular amyloid- β in Alzheimer's disease. Nature Reviews Neuroscience 2007 8 7 499 509 2-s2.0-34250819839 10.1038/nrn2168 (Pubitemid 46985362)
17. Nimchinsky E. A., Sabatini B. L., Svoboda K., Structure and function of dendritic spines. Annual Review of Physiology 2002 64 313 353 2-s2.0-0036194016 10.1146/annurev.physiol.64.081501.160008 (Pubitemid 34259233)
18. Alvarez V. A., Sabatini B. L., Anatomical and physiological plasticity of dendritic spines. Annual Review of Neuroscience 2007 30 79 97 2-s2.0-34249933552 10.1146/annurev.neuro.30.051606.094222 (Pubitemid 47218752)
19. Smith D. L., Pozueta J., Gong B., Arancio O., Shelanski M., Reversal of long-term dendritic spine alterations in Alzheimer disease models. Proceedings of the National Academy of Sciences of the United States of America 2009 106 39 16877 16882 2-s2.0-70349755717 10.1073/pnas.0908706106
20. Jain S., Yoon S. Y., Leung L., Knoferle J., Huang Y., Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development. PLoS ONE 2013 8 3 2-s2.0-84875111700 10.1371/journal.pone.0059478 e59478
21. Morrison J. H., Baxter M. G., The ageing cortical synapse: Hallmarks and implications for cognitive decline. Nature Reviews Neuroscience 2012 13 4 240 250 2-s2.0-84858702953 10.1038/nrn3200
22. Luebke J. I., Weaver C. M., Rocher A. B., Rodriguez A., Crimins J. L., Dickstein D. L., Wearne S. L., Hof P. R., Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models. Brain Structure and Function 2010 214 2-3 181 199 2-s2.0-77950458272 10.1007/s00429-010-0244-2
23. Bhatt D. H., Zhang S., Gan W.-B., Dendritic spine dynamics. Annual Review of Physiology 2009 71 261 282 2-s2.0-67651165504 10.1146/annurev.physiol. 010908.163140
24. Matsuzaki M., Honkura N., Ellis-Davies G. C. R., Kasai H., Structural basis of long-term potentiation in single dendritic spines. Nature 2004 429 6993 761 766 2-s2.0-3042554012 10.1038/nature02617 (Pubitemid 38833127)
25. 1-40 injection in rat hippocampus. Neurological Sciences 2013 2-s2.0-84878120534 10.1007/s10072-013-1463-0
26. Chacón M. A., Barría M. I., Soto C., Inestrosa N. C., β -sheet breaker peptide prevents A β -induced spatial memory impairments with partial reduction of amyloid deposits. Molecular Psychiatry 2004 9 10 953 961 2-s2.0-6044240725 10.1038/sj.mp.4001516 (Pubitemid 39381959)
27. 1-42-mediated neurotoxicity by regulating calcium homeostasis and ameliorating oxidative stress in hippocampus of rats. Journal of the Neurological Sciences 2009 280 1-2 71 78 2-s2.0-63349109688 10.1016/j.jns.2009. 01.027
28. Gong X., Lu X., Zhan L., Sui H., Qi X., Ji Z., Niu X., Liu L., Role of the SNK-SPAR pathway in the development of Alzheimer's disease. IUBMB Life 2010 62 3 214 221 2-s2.0-77951100396 10.1002/iub.308
29. Li J., Wang G., Liu J., Zhou L., Dong M., Wang R., Li X., Li X., Lin C., Niu Y., Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo. European Journal of Pharmacology 2010 649 1-3 195 201 2-s2.0-78049296008 10.1016/j.ejphar.2010.09. 045
30. 1-42 oligomer injection. Neurobiology of Learning and Memory 2011 96 2 306 314 2-s2.0-79960841704 10.1016/j.nlm.2011.06.004
31. Jantaratnotai N., Ryu J. K., Schwab C., McGeer P. L., McLarnon J. G., Comparison of vascular perturbations in an A β -injected animal model and in AD brain. International Journal of Alzheimer's Disease 2011 2011 8 2-s2.0-81555214519 10.4061/2011/918280 918280
32. 1-42 level by upregulating PPAR γ and IDE expression in the hippocampus of a rat model of Alzheimer's disease. PLoS ONE 2013 8 3 2-s2.0-84874786893 10.1371/journal.pone.0059155 e59155
33. He P., Ouyang X., Zhou S., Yin W., Tang C., Laudon M., Tian S., A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease. Hormones and Behavior 2013 64 1 1 7 2-s2.0-84878862568 10.1016/j.yhbeh.2013.04.009
34. Liu X.-J., Yuan L., Yang D., Han W.-N., Li Q.-S., Yang W., Liu Q.-S., Qi J.-S., Melatonin protects against amyloid- β -induced impairments of hippocampal LTP and spatial learning in rats. Synapse 2013 67 9 626 636 2-s2.0-84880574849 10.1002/syn.21677
35. 1-42 inhibits neurogenesis and down-regulates IFN- γ and NF- B expression in hippocampus of adult mouse brain. Amyloid 2013 20 1 13 20 2-s2.0-84874169147 10.3109/13506129.2012.755122
36. 1-42 oligomers injected into the hippocampus. Hormones and Behavior 2013 64 3 477 486
37. 25-35 induced learning and memory impairments in male rats. Pharmacology Biochemistry and Behavior 2013 106 77 84 2-s2.0-84876003481 10.1016/j.pbb.2013.03.005
38. Zhang J., Zhena Y.-F., Song L.-G., Kong W.-N., Shao T.-M., Li X., Chai X.-Q., Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus. Behavioural Brain Research 2013 244 70 81 2-s2.0-84874390596 10.1016/j.bbr.2013.01.037
39. Bishop G. M., Robinson S. R., The amyloid hypothesis: let sleeping dogmas lie? Neurobiology of Aging 2002 23 6 1101 1105 2-s2.0-0036833988
40. Wei W., Nguyen L. N., Kessels H. W., Hagiwara H., Sisodia S., Malinow R., Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nature Neuroscience 2010 13 2 190 196 2-s2.0-75549092259 10.1038/nn.2476
41. Chang P. K.-Y., Boridy S., McKinney R. A., Maysinger D., Letrozole potentiates mitochondrial and dendritic spine impairments induced by β amyloid. Journal of Aging Research 2013 2013 11 2-s2.0-84881412677 10.1155/2013/538979 538979
42. Meng C., He Z., Xing D., Low-level laser therapy rescues dendrite atrophy via upregulating BDNF expression: implications for Alzheimer's disease. Journal of Neuroscience 2013 33 33 13505 13517 2-s2.0-84881498826 10.1523/JNEUROSCI. 0918-13.2013
43. Nath S., Agholme L., Kurudenkandy F. R., Granseth B., Marcusson J., Hallbeck M., Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β -amyloid. Journal of Neuroscience 2012 32 26 8767 8777 2-s2.0-84862868531 10.1523/JNEUROSCI.0615-12.2012
44. Leuner B., Mendolia-Loffredo S., Kozorovitskiy Y., Samburg D., Gould E., Shors T. J., Learning enhances the survival of new neurons beyond the time when the hippocampus is required for memory. Journal of Neuroscience 2004 24 34 7477 7481 2-s2.0-4444381084 10.1523/JNEUROSCI.0204-04.2004 (Pubitemid 39166738)
45. Leuner B., Shors T. J., New spines, new memories. Molecular Neurobiology 2004 29 2 117 130 2-s2.0-3142700003 10.1385/MN:29:2:117 (Pubitemid 40104477)
46. 1-42" physicochemical and biological characterization. Peptides 2010 31 2 248 256 2-s2.0-73949154685 10.1016/j.peptides.2009.12.001
47. Paxinos G., Watson C., The Rat Brain in Stereotaxic Coordinates 1982 London, UK Academic Press
48. Nagy D., Kocsis K., Fuzik J., Marosi M., Kis Z., Teichberg V. I., Toldi J., Farkas T., Kainate postconditioning restores LTP in ischemic hippocampal CA1: onset-dependent second pathophysiological stress. Neuropharmacology 2011 61 5-6 1026 1032 2-s2.0-80051792518 10.1016/j.neuropharm.2011.07.005
49. Selkoe D. J., Alzheimer's disease is a synaptic failure. Science 2002 298 5594 789 791 2-s2.0-0037174618 10.1126/science.1074069 (Pubitemid 35231524)
50. Lacor P. N., Buniel M. C., Chang L., Fernandez S. J., Gong Y., Viola K. L., Lambert M. P., Velasco P. T., Bigio E. H., Finch C. E., Krafft G. A., Klein W. L., Synaptic targeting by Alzheimer's-related amyloid β oligomers. Journal of Neuroscience 2004 24 45 10191 10200 2-s2.0-20844458090 10.1523/JNEUROSCI.3432-04.2004 (Pubitemid 39492046)
51. Lacor P. N., Buniel M. C., Furlow P. W., Clemente A. S., Velasco P. T., Wood M., Viola K. L., Klein W. L., A β oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. Journal of Neuroscience 2007 27 4 796 807 2-s2.0-33846633336 10.1523/JNEUROSCI.3501-06.2007 (Pubitemid 46174498)
52. Grutzendler J., Helmin K., Tsai J., Gan W.-B., Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Annals of the New York Academy of Sciences 2007 1097 30 39 2-s2.0-34247639567 10.1196/annals.1379.003 (Pubitemid 47084880)
53. Kirkwood C. M., Ciuchta J., Ikonomovic M. D., Fish K. N., Abrahamson E. E., Murray P. S., Klunk W. E., Sweet R. A., Dendritic spine density, morphology, and fibrillar actin content surrounding amyloid- β plaques in a mouse model of amyloid- β deposition. Journal of Neuropathology and Experimental Neurology 2013 72 8 791 800 2-s2.0-84880918212 10.1097/NEN.0b013e31829ecc89
54. Le R., Cruz L., Urbanc B., Knowles R. B., Hsiao-Ashe K., Duff K., Irizarry M. C., Stanley H. E., Hyman B. T., Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption. Journal of Neuropathology and Experimental Neurology 2001 60 8 753 758 2-s2.0-0034918436 (Pubitemid 32678255)
55. Sandberg A., Luheshi L. M., Sollvander S., Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering. Proceedings of the National Academy of Sciences of the United States of America 2010 107 35 15595 15600
56. Feria-Velasco A., del Angel A. R., Gonzalez-Burgos I., Modification of dendritic development. Progress in Brain Research 2002 136 135 143 2-s2.0-0036454516 10.1016/S0079-6123(02)36013-8 (Pubitemid 35460974)
57. Kramer M. L., Schulz-Schaeffer W. J., Presynaptic α -synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with lewy bodies. Journal of Neuroscience 2007 27 6 1405 1410 2-s2.0-33846997878 10.1523/JNEUROSCI.4564-06.2007
58. Overk C. R., Masliah E., Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease. Biochemical Pharmacology 2014 88 4 508 516
59. Murmu R. P., Li W., Holtmaat A., Li J.-Y., Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of huntington's disease. Journal of Neuroscience 2013 33 32 12997 13009 2-s2.0-84881148047 10.1523/JNEUROSCI.5284-12.2013